Unger, Joseph M <br/><br/>
The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials.  [electronic resource] 

 -  Cancer epidemiology  08 2018 
 - 117-122 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1877-783X 
<br/><br/><label>Standard No.: </label>10.1016/j.canep.2018.06.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Biomedical Research<br/>Breast Neoplasms--drug therapy<br/>Clinical Trials, Phase III as Topic<br/>Female<br/>Humans<br/>Male<br/>National Cancer Institute (U.S.)<br/>Periodicals as Topic--statistics & numerical data<br/>Prostatic Neoplasms--drug therapy<br/>Randomized Controlled Trials as Topic<br/>Survival Rate<br/>Treatment Outcome<br/>United States